sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
27-Aug-2016 22:21
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 576-600 out of 1294.

<< < 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>

Public Release: 13-Oct-2015
Cancer Cell
Armed malaria protein found to kill cancer cells
In models of non-Hodgkin's lymphoma, castration-resistant prostate cancer, and metastatic breast cancer, the Kairos-VAR2 therapeutic demonstrated the ability to prevent tumor growth, regress established tumors, and cure metastatic disease. The studies were published today in the journal Cancer Cell.

Contact: John Babcook
jbabcook@cdrd.ca
604-862-5912
The Centre for Drug Research and Development

Public Release: 13-Oct-2015
Scientific Reports
Antiviral favipiravir successfully treats Lassa virus in guinea pigs
Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a new study from NIH scientists and colleagues.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Ken Pekoc
kpekoc@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 13-Oct-2015
PLOS ONE
In dryland African regions, limiting wildlife water access can reduce water quality
Water-dependent wildlife populations in sensitive African dryland regions need continued access to limited surface water resources -- even as human development increases in these areas -- because restricting access and concentrating wildlife populations along riparian regions can impact water quality and, potentially, human health.

Contact: Lynn Davis
davisl@vt.edu
540-231-6157
Virginia Tech

Public Release: 13-Oct-2015
£3.5 million grant to improve prevention of tuberculosis in South African schoolchildren
The Medical Research Council has awarded a grant of £3.5 million to researchers from Queen Mary University of London and University of Cape Town to carry out a trial to determine whether a weekly vitamin D supplement can prevent tuberculosis in South African primary school children.
Medical Research Council

Contact: Rupert Marquand
r.marquand@qmul.ac.uk
07-817-989-532
Queen Mary University of London

Public Release: 13-Oct-2015
Nature Medicine
New study has important implications for the design of a protective HIV vaccine
A Ph.D. student from Wits University published a study describing how the changing viral swarm in an HIV infected person can drive the generation of antibodies able to neutralize HIV strains from across the world. The study has important implications for the design of a protective HIV vaccine.

Contact: Kemantha Govender
kemantha.govender1@wits.ac.za
011-717-1024
University of the Witwatersrand

Public Release: 13-Oct-2015
Nature Communications
Tulane researchers working on new tuberculosis vaccine
Researchers at the Tulane National Primate Research Center are leading efforts to find a new vaccine for tuberculosis, one of the world's deadliest diseases. A team of researchers led by the TNPRC used a modified strain of TB to show that monkeys could generate better protective immunity than when vaccinated with BCG, a common TB vaccine.
National Institutes of Health

Contact: Carolyn Scofield
cscofiel@tulane.edu
504-247-1443
Tulane University

Public Release: 13-Oct-2015
Cancer Cell
Destructive disease shows potential as a cancer treatment
Scientists at the University of British Columbia, Vancouver Coastal Health and the BC Cancer Agency have discovered a protein from malaria that could one day help stop cancer in its tracks.

Contact: Faydra Aldridge
faydra.aldridge@vch.ca
604-875-4111 x66687
University of British Columbia

Public Release: 12-Oct-2015
Nature Communications
Genes linked with malaria's virulence shared by apes, humans
The malaria parasite molecules associated with severe disease and death have been shown to share key gene segments with chimp and gorilla malaria parasites, which are separated by several millions of years, according to a new study led by Harvard T.H. Chan School of Public Health. This new information could aid in basic understanding of the causes of malaria and provide targets for drugs and vaccines.
National Institutes of Health, Wellcome Trust

Contact: Marge Dwyer
mhdwyer@hsph.harvard.edu
617-432-8416
Harvard T.H. Chan School of Public Health

Public Release: 12-Oct-2015
American Journal of Tropical Medicine and Hygiene
Comprehensive genomic study provides evidence that dengue has become endemic and diverse in China
The first-ever comprehensive genomic analysis of the virus that causes dengue fever suggests that it may survive year-round in southern China. The study, published in the American Journal of Tropical Medicine and Hygiene, provides evidence that China may be at increased risk for more frequent and severe dengue fever outbreaks similar to the 2014 outbreak in Guangdong Province that sickened more than 40,000 people.

Contact: Bridget DeSimone
bdesimone@burness.com
301-280-5735
Burness

Public Release: 9-Oct-2015
IDWeek 2015
Antiviral compound provides full protection from Ebola virus in nonhuman primates
Rhesus monkeys were completely protected from the deadly Ebola virus when treated three days after infection with a compound that blocks the virus's ability to replicate. These encouraging preclinical results suggest the compound, known as GS-5734, should be further developed as a potential treatment, according to research findings to be presented tomorrow at the IDWeek conference.
Defense Threat Reduction Agency, Medical Countermeasure Systems Joint Project Management Office, US Department of Defense

Contact: Caree Vander Linden
teresa.l.vanderlinden.civ@mail.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases

Public Release: 8-Oct-2015
US and Canada partner to invest $21 million for research hubs in developing countries
The National Institutes of Health and other US and Canadian partners are investing $20.9 million dollars over five years to establish seven regional research and training centers in low- and middle-income countries. The Global Environmental and Occupational Health Hubs will consist of multidisciplinary groups of researchers and partner organizations collaborating on common research and training topics that address environmental and/or occupational health issues.
National Institutes of Health, National Institute for Occupational Safety and Health, Canadian International Development Research Centre, Global Alliance for Clean Cookstoves

Contact: Ann Puderbaugh
ann.puderbaugh@nih.gov
301-496-2075
NIH/Fogarty International Center

Public Release: 8-Oct-2015
Water, Air and Soil Journal
Ben-Gurion U. and MIT researchers develop rapid method for water, soil pathogen screening
The study, published online in the Water, Air & Soil Pollution journal (Springer) defines an accurate, inexpensive, high-throughput, and rapid alternative for screening of pathogens from various environmental samples. 'This is the first study to comprehensively assess pathogen concentrations in such a broad variety of environmental sample types while achieving multiple pathogen detection with complete parallel testing by standard (or traditional) methods,' Orlofsky explains.
U.S.-Israel Binational Agricultural Research and Development Fund, Israel Water Authority, BGU's Kreitman School for Graduate Studies, and Maccabi Fund

Contact: andrew Lavin
andrewlavin@alavin.com
516-353-2505
American Associates, Ben-Gurion University of the Negev

Public Release: 8-Oct-2015
Clinical Infectious Diseases
Salmonella unmasked as major killer of young children in Africa
Invasive Salmonella infections in sub-Saharan Africa are a major cause of child illness and deaths, a new body of research into this usually overlooked infectious disease has revealed. In the West, Salmonella is commonly thought of as a bacterium responsible for relatively benign cases of food poisoning. However, a supplement to the leading infectious diseases journal Clinical Infectious Diseases published today now exposes the unacceptable toll of sickness and death caused by invasive Salmonella infections in sub-Saharan Africa.
Bill & Melinda Gates Foundation, Wellcome Trust

Contact: John Crump
john.crump@otago.ac.nz
64-347-99460
University of Otago

Public Release: 6-Oct-2015
Proceedings of the National Academy of Sciences
Study: Link between dengue epidemics and high temperatures during strong El Niño season
Epidemics of dengue are linked to high temperatures brought by the El Niño weather phenomenon, a University of Florida scientist working with an international team of researchers has found.
Bill & Melinda Gates Foundation, NIH/National Institute of General Medical Sciences

Contact: Derek Cummings
datc@ufl.edu
352-392-1107
University of Florida

Public Release: 6-Oct-2015
Tufts biophysicist receives NIH New Innovator Award for Ebola research
James Munro of Tufts University School of Medicine is a recipient of the 2015 National Institutes of Health Director's New Innovator Award. Munro is using imaging of glycoproteins to investigate how Ebola and related viruses enter host cells. Understanding this process is expected to help develop vaccines for Ebola and related viruses.
National Institutes of Health

Contact: Siobhan Gallagher
siobhan.gallagher@tufts.edu
Tufts University, Health Sciences Campus

Public Release: 5-Oct-2015
Journal of Virology
Dengue protein modulates human enzyme: Fuel for replication
A new study published in the Journal of Virology reveals that NS1, a nonstructural protein composing the replication machinery of the dengue virus, binds to a well-known human enzyme as a way to increase energy production to be used for viral replication.

Contact: Ronaldo Mohana Borges
mohana@biof.ufrj.br
55-213-938-6538
Publicase Comunicação Científica

Public Release: 5-Oct-2015
Journal of Advanced Nursing
How health professionals help and hinder eradication of female genital mutilation
A new article highlights how health professionals -- including nurses and midwives -- both help and hinder eradication and management of female genital mutilation.

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley

Public Release: 5-Oct-2015
European Journal of Neurology
Africa faces rising rates of traumatic brain injury
New research reveals that the projected estimates of traumatic brain injury in Africa are high, with a burden of anywhere between approximately 6 to 14 million new cases in 2050. Most cases will result from motor vehicle accidents.

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley

Public Release: 5-Oct-2015
EU funding to support chronic lung disease research
Researchers from Plymouth University Peninsula Schools of Medicine and Dentistry are part of an international consortium which has received funding of almost €3 million from the EU Horizon 2020 programme, to investigate methods to prevent, diagnose and treat non-communicable lung disease (such as asthma and chronic pulmonary obstructive disorder - COPD) in low and middle income countries.
Horizon 2020

Contact: Andrew Gould
andrew.gould@plymouth.ac.uk
University of Plymouth

Public Release: 5-Oct-2015
Proceedings of the National Academy of Sciences
Dengue epidemics linked to high temperatures during strong El Nino season
An international research team led by the University of Pittsburgh Graduate School of Public Health has shown that epidemics of dengue, which is caused by a mosquito-borne virus, across southeast Asia appear to be linked to the abnormally high temperatures brought by the El Niño weather phenomenon. Now, as the most intense El Niño in nearly two decades is emerging in the Pacific, the finding may be a harbinger of a spike in cases.
NIH/National Institute of General Medical Sciences

Contact: Allison Hydzik
hydzikam@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences

Public Release: 2-Oct-2015
Technology
Pneumothorax treatment gets less painful
Scientists working in Tianjin Chest Hospital, China, have developed a less painful treatment strategy for Pneumothorax treatment. By analyzing the partial pressure of oxygen and carbon dioxide in thoracic cavity gas during Pneumothorax Treatment, physicians can understand the real conditions of the pneumothorax and then update to a less painful treatment method.

Contact: Philly Lim
mllim@wspc.com.sg
65-646-65775
World Scientific

Public Release: 2-Oct-2015
Science Advances
UBC researchers create self-propelled powder to stop bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.

Contact: Christian Kastrup
ckastrup@mail.ubc.ca
604-837-1371
University of British Columbia

Public Release: 1-Oct-2015
Journal of National Cancer Institute
Rising cancer rates in low and middle income countries threaten economic stability
The rising cost of treating and caring for a growing number of cancer patients threatens economic development in low and middle income countries, making prevention key.
American Cancer Society, International Agency for Research on Cancer, Imperial College London

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society

Public Release: 30-Sep-2015
Biomaterials
Penn Dental Medicine study is proof-of-concept for low-cost drug made in lettuce
At the University of Pennsylvania School of Dental Medicine, Henry Daniell and colleagues have used a plant-based system to make shelf-stable drugs. In a study published in the journal Biomaterials, the researchers confirmed the viability of their method for FDA approval and human use, producing an effective drug that promotes tolerance to clotting factors, which could be taken by hemophilia patients, using freeze-dried lettuce leaves.
Novo Nordisk, National Institutes of Health, National Nature Science Foundation of China

Contact: Katherine Unger Baillie
kbaillie@upenn.edu
215-898-9194
University of Pennsylvania

Public Release: 30-Sep-2015
Science Translational Medicine
Latest technology could help curb repeat Ebola crisis, experts say
Recent developments in surveillance technology could enable a swifter, more effective response to potentially deadly outbreaks of disease, and technology could help improve the response, a study has found.
Wellcome Trust, EU Horizon 2020 Programme (COMPARE)

Contact: Catriona Kelly
Catriona.Kelly@ed.ac.uk
44-131-651-4401
University of Edinburgh

Showing releases 576-600 out of 1294.

<< < 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>